Induced Pluripotent Stem Cells Generated Without Viral Integration
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Pluripotent stem cells have been generated from mouse and human somatic cells by viral expression of the transcription factors Oct4, Sox2, Klf4, and c-Myc. A major limitation of this technology is the use of potentially harmful genome-integrating viruses. We generated mouse induced pluripotent stem (iPS) cells from fibroblasts and liver cells by using nonintegrating adenoviruses transiently expressing Oct4, Sox2, Klf4, and c-Myc. These adenoviral iPS (adeno-iPS) cells show DNA demethylation characteristic of reprogrammed cells, express endogenous pluripotency genes, form teratomas, and contribute to multiple tissues, including the germ line, in chimeric mice. Our results provide strong evidence that insertional mutagenesis is not required for in vitro reprogramming. Adenoviral reprogramming may provide an improved method for generating and studying patient-specific stem cells and for comparing embryonic stem cells and iPS cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adenovirus and Sendai virus-mediated vector delivery provide alternative non-integrative methods for iPSC reprogramming [24,25,26,27,28].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Self-citationReprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Self-citationHuangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606
Dissecting direct reprogramming through integrative genomic analysis
Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B. E., Jaenisch, R., Lander, E. S., & Meissner, A. (2008) · Nature · doi:10.1038/nature07056 · Cited by 1,480
Wernig, M., Zhao, J.-P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., Broccoli, V., Constantine-Paton, M., Isacson, O., & Jaenisch, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801677105 · Cited by 1,216
Research works printed but not linked: 1
- S. Eminli J. Utikal K. Arnold R. Jaenisch K. Hochedlinger Stem Cells published online 17June2008 in press.
Cited by
Items 101–200 of 1,002
Reprogramming human fibroblasts to pluripotency using modified mRNA
Mandal, P. K., & Rossi, D. J. (2013) · Nature Protocols · doi:10.1038/nprot.2013.019 · Cited by 221
Si-Tayeb, K., Noto, F. K., Sepac, A., Sedlic, F., Bosnjak, Z. J., Lough, J. W., & Duncan, S. A. (2010) · BMC Developmental Biology · doi:10.1186/1471-213x-10-81 · Cited by 220
Ahuja, C. S., & Fehlings, M. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0381 · Cited by 220
Chang, C.-W., Lai, Y.-S., Pawlik, K. M., Liu, K., Sun, C.-W., Li, C., Schoeb, T. R., & Townes, T. M. (2009) · Stem Cells · doi:10.1002/stem.39 · Cited by 217
Generation of mouse-induced pluripotent stem cells with plasmid vectors
Okita, K., Hong, H., Takahashi, K., & Yamanaka, S. (2010) · Nature Protocols · doi:10.1038/nprot.2009.231 · Cited by 216
Human iPSC banking: barriers and opportunities
Huang, C.-Y., Liu, C.-L., Ting, C.-Y., Chiu, Y.-T., Cheng, Y.-C., Nicholson, M. W., & Hsieh, P. C. H. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0578-x · Cited by 216
Ye, L., Chang, J. C., Lin, C., Sun, X., Yu, J., & Kan, Y. W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904689106 · Cited by 216
Pluripotent Stem Cells: Current Understanding and Future Directions
Romito, A., & Cobellis, G. (2016) · Stem Cells International · doi:10.1155/2016/9451492 · Cited by 215
Stem Cell Therapy in Heart Diseases – Cell Types, Mechanisms and Improvement Strategies
Müller, P., Lemcke, H., & David, R. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492704 · Cited by 215
Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors
Narsinh, K. H., Jia, F., Robbins, R. C., Kay, M. A., Longaker, M. T., & Wu, J. C. (2011) · Nature Protocols · doi:10.1038/nprot.2010.173 · Cited by 214
Bilic, J., & Belmonte, J. C. I. (2012) · STEM CELLS · doi:10.1002/stem.700 · Cited by 210
Kwon, H., Kim, M., Seo, Y., Moon, Y. S., Lee, H. J., Lee, K., & Lee, H. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.034 · Cited by 208
Molecular and Cellular Regulation of Skeletal Myogenesis
Comai, G., & Tajbakhsh, S. (2014) · Current Topics in Developmental Biology · doi:10.1016/b978-0-12-405943-6.00001-4 · Cited by 208
Omole, A. E., & Fakoya, A. O. J. (2018) · PeerJ · doi:10.7717/peerj.4370 · Cited by 204
Pluripotent Stem Cells Derived From Adult Human Testes
Golestaneh, N., Kokkinaki, M., Pant, D., Jiang, J., DeStefano, D., Fernandez-Bueno, C., Rone, J. D., Haddad, B. R., Gallicano, G. I., & Dym, M. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0347 · Cited by 202
C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells
Di Stefano, B., Sardina, J. L., van Oevelen, C., Collombet, S., Kallin, E. M., Vicent, G. P., Lu, J., Thieffry, D., Beato, M., & Graf, T. (2014) · Nature · doi:10.1038/nature12885 · Cited by 200
Embryonic and adult stem cell therapy
Brignier, A. C., & Gewirtz, A. M. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.032 · Cited by 199
Young, M. A., Larson, D. E., Sun, C.-W., George, D. R., Ding, L., Miller, C. A., Lin, L., Pawlik, K. M., Chen, K., Fan, X., et al. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.03.002 · Cited by 197
Stem Cell Therapy for Vascular Regeneration: Adult, Embryonic, and Induced Pluripotent Stem Cells
Leeper, N. J., Hunter, A. L., & Cooke, J. P. (2010) · Circulation · doi:10.1161/circulationaha.109.881441 · Cited by 195
The therapeutic potential of stem cells
Watt, F. M., & Driskell, R. R. (2010) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2009.0149 · Cited by 195
Advances in Reprogramming Somatic Cells to Induced Pluripotent Stem Cells
Patel, M., & Yang, S. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9123-8 · Cited by 193
Induced pluripotent stem cells: at the heart of cardiovascular precision medicine
Chen, I. Y., Matsa, E., & Wu, J. C. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.36 · Cited by 191
Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming
Li, W., & Ding, S. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.10.002 · Cited by 191
Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape
Papp, B., & Plath, K. (2011) · Cell Research · doi:10.1038/cr.2011.28 · Cited by 188
Cai, J., Li, W., Su, H., Qin, D., Yang, J., Zhu, F., Xu, J., He, W., Guo, X., Labuda, K., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.086389 · Cited by 184
Generating a Non-Integrating Human Induced Pluripotent Stem Cell Bank from Urine-Derived Cells
Xue, Y., Cai, X., Wang, L., Liao, B., Zhang, H., Shan, Y., Chen, Q., Zhou, T., Li, X., Hou, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070573 · Cited by 183
Wang, D., Quan, Y., Yan, Q., Morales, J. E., & Wetsel, R. A. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0049 · Cited by 180
Mallanna, S. K., & Rizzino, A. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.05.014 · Cited by 180
Vallier, L., Touboul, T., Brown, S., Cho, C., Bilican, B., Alexander, M., Cedervall, J., Chandran, S., Ährlund-Richter, L., Weber, A., et al. (2009) · Stem Cells · doi:10.1002/stem.199 · Cited by 174
Stem cell therapy for type 1 diabetes mellitus
Aguayo-Mazzucato, C., & Bonner-Weir, S. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.274 · Cited by 174
Human stem cells and drug screening: opportunities and challenges
Ebert, A. D., & Svendsen, C. N. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3000 · Cited by 172
Yoshida, Y., & Yamanaka, S. (2010) · Circulation · doi:10.1161/circulationaha.109.881433 · Cited by 172
Latest Insights on Adenovirus Structure and Assembly
San Martín, C. (2012) · Viruses · doi:10.3390/v4050847 · Cited by 172
iPS cells: A source of cardiac regeneration
Yoshida, Y., & Yamanaka, S. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.026 · Cited by 171
Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells
Li, C., Zhou, J., Shi, G., Ma, Y., Yang, Y., Gu, J., Yu, H., Jin, S., Wei, Z., Chen, F., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp386 · Cited by 170
Smith, A. S. T., Macadangdang, J. R., Leung, W. W., Laflamme, M. A., & Kim, D. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.12.002 · Cited by 169
Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells
Kaufman, D. S. (2009) · Blood · doi:10.1182/blood-2009-03-191304 · Cited by 168
Induced Pluripotent Stem Cells and Their Potential for Basic and Clinical Sciences
Ye, L., Swingen, C., & Zhang, J. J. (2013) · Current Cardiology Reviews · doi:10.2174/157340313805076278 · Cited by 168
Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives
Zomer, H. D., Vidane, A. S., Gonçalves, N. N., & Ambrósio, C. E. (2015) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s88036 · Cited by 168
Microscale electroporation: challenges and perspectives for clinical applications
Lee, W. G., Demirci, U., & Khademhosseini, A. (2009) · Integrative Biology · doi:10.1039/b819201d · Cited by 167
Stem Cell Therapy to Cure Type 1 Diabetes: From Hype to Hope
Chhabra, P., & Brayman, K. L. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0116 · Cited by 164
Neural grafting in Parkinson’s disease
Brundin, P., Barker, R. A., & Parmar, M. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84014-2 · Cited by 162
Spermatogonial stem cells: Mouse and human comparisons
Dym, M., Kokkinaki, M., & He, Z. (2009) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20141 · Cited by 161
Articular Cartilage Tissue Engineering
Athanasiou, K. A., Darling, E. M., & Hu, J. C. Y. (2009) · Synthesis lectures on tissue engineering · doi:10.2200/s00212ed1v01y200910tis003 · Cited by 161
Good Cell Culture Practice for stem cells and stem-cell-derived models
Pamies, D. (2016) · ALTEX · doi:10.14573/altex.1607121 · Cited by 160
Present state and future perspectives of using pluripotent stem cells in toxicology research
Wobus, A. M., & Löser, P. (2011) · Archives of Toxicology · doi:10.1007/s00204-010-0641-6 · Cited by 159
Cai, J., Yang, M., Poremsky, E., Kidd, S. K., Schneider, J. S., & Iacovitti, L. (2009) · Stem Cells and Development · doi:10.1089/scd.2009.0319 · Cited by 158
Chemical Control of Stem Cell Fate and Developmental Potential
Lyssiotis, C. A., Lairson, L. L., Boitano, A. E., Wurdak, H., Zhu, S., & Schultz, P. G. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201004284 · Cited by 157
A gene expression signature shared by human mature oocytes and embryonic stem cells
Assou, S., Cerecedo, D., Tondeur, S., Pantesco, V., Hovatta, O., Klein, B., Hamamah, S., & Vos, J. D. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-10 · Cited by 154
Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells
VandenDriessche, T., Ivics, Z., Izsvák, Z., & Chuah, M. K. L. (2009) · Blood · doi:10.1182/blood-2009-04-210427 · Cited by 151
Developing safe therapies from human pluripotent stem cells
Carpenter, M. K., Frey-Vasconcells, J. L., & Rao, M. S. (2009) · Nature Biotechnology · doi:10.1038/nbt0709-606 · Cited by 150
Oct4 and Klf4 Reprogram Dermal Papilla Cells into Induced Pluripotent Stem Cells
Tsai, S., Clavel, C., Kim, S., Ang, Y.-S., Grisanti, L., Lee, D., Kelley, K. A., & Rendl, M. (2009) · Stem Cells · doi:10.1002/stem.281 · Cited by 149
Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke
Wei, L., Wei, Z. Z., Jiang, M. Q., Mohamad, O., & Yu, S. P. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.003 · Cited by 149
A simple method for deriving functional MSCs and applied for osteogenesis in 3D scaffolds
Zou, L., Luo, Y., Chen, M., Wang, G., Ding, M. L., Petersen, C. C., Kang, R., Dagnæs‐Hansen, F., Zeng, Y., Lv, N., et al. (2013) · Scientific Reports · doi:10.1038/srep02243 · Cited by 148
Klf4 Interacts Directly with Oct4 and Sox2 to Promote Reprogramming
Wei, Z., Yang, Y., Zhang, P., Andrianakos, R., Hasegawa, K., Lyu, J., Chen, X., Bai, G., Liu, C., Pera, M., et al. (2009) · Stem Cells · doi:10.1002/stem.231 · Cited by 146
Murphy, S. V., & Atala, A. (2012) · BioEssays · doi:10.1002/bies.201200062 · Cited by 143
Tashiro, K., Inamura, M., Kawabata, K., Sakurai, F., Yamanishi, K., Hayakawa, T., & Mizuguchi, H. (2009) · Stem Cells · doi:10.1002/stem.108 · Cited by 142
Stem cells in gastroenterology and hepatology
Quante, M., & Wang, T. C. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.195 · Cited by 141
Nanomedicine-Based Approaches for mRNA Delivery
Uchida, S., Perche, F., Pichon, C., & Cabral, H. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00618 · Cited by 139
Force, T., & Woodgett, J. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800077200 · Cited by 139
Induced pluripotent stem cells: developmental biology to regenerative medicine
Nelson, T. J., Martinez‐Fernandez, A., & Terzic, A. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.159 · Cited by 138
Articular Cartilage Tissue Engineering
Athanasiou, K. A., Darling, E. M., & Hu, J. C. Y. (2010) · Synthesis lectures on tissue engineering · doi:10.1007/978-3-031-02578-5 · Cited by 137
Progress in the Reprogramming of Somatic Cells
Ma, T., Xie, M., Laurent, T., & Ding, S. (2013) · Circulation Research · doi:10.1161/circresaha.111.249235 · Cited by 135
Immunological Applications of Stem Cells in Type 1 Diabetes
Fiorina, P., Voltarelli, J., & Zavazava, N. (2011) · Endocrine Reviews · doi:10.1210/er.2011-0008 · Cited by 135
Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement Therapy
Al Abbar, A., Ngai, S. C., Nograles, N., Alhaji, S. Y., & Abdullah, S. (2020) · BioResearch Open Access · doi:10.1089/biores.2019.0046 · Cited by 134
Tomioka, I., Maeda, T., Shimada, H., Kawai, K., Okada, Y., Igarashi, H., Oiwa, R., Iwasaki, T., Aoki, M., Kimura, T., et al. (2010) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01437.x · Cited by 131
Cieślar‐Pobuda, A., Knoflach, V., Ringh, M. V., Stark, J., Likus, W., Siemianowicz, K., Ghavami, S., Hudecki, A., Green, J. L., & Łoś, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.04.017 · Cited by 130
Renewed proliferation in adult mouse cochlea and regeneration of hair cells
Shu, Y., Li, W., Huang, M., Quan, Y., Scheffer, D. I., Tian, C., Tao, Y., Liu, X. Z., Hochedlinger, K., Indzhykulian, A. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13157-7 · Cited by 129
Self-citationStem Cells Therapy for Spinal Cord Injury
Gazdic, M., Volarević, V., Harrell, C. R., Fellabaum, C., Jovicic, N. U., Arsenijević, N., & Stojković, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041039 · Cited by 129
The Importance of Ubiquitination and Deubiquitination in Cellular Reprogramming
Suresh, B., Lee, J., Kim, K.-S., & Ramakrishna, S. (2016) · Stem Cells International · doi:10.1155/2016/6705927 · Cited by 128
Ahmed, R. P. H., Ashraf, M., Buccini, S., Shujia, J., & Haider, H. K. (2011) · Regenerative Medicine · doi:10.2217/rme.10.103 · Cited by 128
Assessing iPSC reprogramming methods for their suitability in translational medicine
Rao, M. S., & Malik, N. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24183 · Cited by 127
Induced pluripotent stem cells: a new revolution for clinical neurology?
Mattis, V. B., & Svendsen, C. N. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70022-9 · Cited by 125
Moretti, A., Bellin, M., Jung, C. B., Thies, T., Takashima, Y., Bernshausen, A., Schiemann, M., Fischer, S., Moosmang, S., Smith, A. G., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-139477 · Cited by 124
Pluripotent Stem Cells: Origin, Maintenance and Induction
Miguel, M. P. D., Fuentes‐Julián, S., & Alcaina, Y. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9170-1 · Cited by 124
Mahairaki, V., Ryu, J., Peters, A., Chang, Q., Li, T., Park, T. S., Burridge, P. W., Talbot, C. C., Asnaghi, L., Martin, L. J., et al. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0511 · Cited by 122
Kidney Organoids and Tubuloids
Yengej, F. A. Y., Jansen, J., Rookmaaker, M. B., Verhaar, M. C., & Clevers, H. C. (2020) · Cells · doi:10.3390/cells9061326 · Cited by 122
Choi, H. Y., Lee, T., Yang, G., Oh, J., Won, J., Han, J., Jeong, G., Kim, J., Kim, J., Kim, B., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.007 · Cited by 121
Luo, M. H., Hannemann, H., Kulkarni, A. S., Schwartz, P. H., O’Dowd, J. M., & Fortunato, E. A. (2010) · Journal of Virology · doi:10.1128/jvi.02161-09 · Cited by 120
Chun, Y. S., Chaudhari, P., & Jang, Y.-Y. (2010) · International Journal of Biological Sciences · doi:10.7150/ijbs.6.796 · Cited by 118
Easley, C. A., Ben-Yehudah, A., Redinger, C. J., Oliver, S. L., Varum, S. T., Eisinger, V. M., Carlisle, D. L., Donovan, P. J., & Schatten, G. P. (2010) · Cellular Reprogramming · doi:10.1089/cell.2010.0011 · Cited by 117
Pluripotency: Toward a gold standard for human ES and iPS cells
Smith, K. P., Luong, M. X., & Stein, G. S. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21681 · Cited by 117
Generation of pancreatic β cells for treatment of diabetes: advances and challenges
Shahjalal, H. M., Abdal Dayem, A., Lim, K. M., Jeon, T.-I., & Cho, S.-G. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1099-3 · Cited by 116
Functional Myogenic Engraftment from Mouse iPS Cells
Darabi, R., Pan, W., Bosnakovski, D., Baik, J., Kyba, M., & Perlingeiro, R. C. R. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9258-2 · Cited by 116
Current Therapeutic Strategies for Stem Cell-Based Cartilage Regeneration
Nam, Y., Rim, Y. A., Lee, J. J., & Ju, J. H. (2018) · Stem Cells International · doi:10.1155/2018/8490489 · Cited by 116
Haridhasapavalan, K. K., Borgohain, M. P., Dey, C., Saha, B., Narayan, G., Kumar, S., & Thummer, R. P. (2019) · Gene · doi:10.1016/j.gene.2018.11.069 · Cited by 115
MSCs vs. iPSCs: Potential in therapeutic applications
Thanaskody, K., Jusop, A. S., Tye, G. J., Zaman, W. S. W. K., Dass, S. A., & Nordin, F. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1005926 · Cited by 115
Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity
Wu, C., & Dunbar, C. E. (2011) · Frontiers of Medicine · doi:10.1007/s11684-011-0159-1 · Cited by 114
Feeder- and serum-free establishment and expansion of human induced pluripotent stem cells
Totonchi, M., Taei, A., Seifinejad, A., Tabebordbar, M., Rassouli, H., Farrokhi, A., Gourabi, H., Aghdami, N., Salekdeh, G. H., & Baharvand, H. (2009) · The International Journal of Developmental Biology · doi:10.1387/ijdb.092903mt · Cited by 114
Transcriptome transfer produces a predictable cellular phenotype
Sul, J., Wu, K. C. ‐., Zeng, F., Jochems, J., Lee, M. T., Kim, T. K., Peritz, T., Buckley, P. T., Cappelleri, D. J., Maronski, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902161106 · Cited by 114
Technological Overview of iPS Induction from Human Adult Somatic Cells
Bayart, E., & Cohen-Haguenauer, O. (2013) · Current Gene Therapy · doi:10.2174/1566523211313020002 · Cited by 113
Feeder-dependent and feeder-independent iPS cell derivation from human and mouse adipose stem cells
Sugii, S., Kida, Y. S., Berggren, W. T., & Evans, R. M. (2011) · Nature Protocols · doi:10.1038/nprot.2010.199 · Cited by 113
Integration-Free Methods for Generating Induced Pluripotent Stem Cells
Zhou, Y., & Zeng, F. (2013) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2013.09.008 · Cited by 113
Thatava, T., Nelson, T. J., Edukulla, R., Sakuma, T., Ohmine, S., Tonne, J. M., Yamada, S., Kudva, Y. C., Terzic, A., & Ikeda, Y. (2010) · Gene Therapy · doi:10.1038/gt.2010.145 · Cited by 112
Induced Pluripotency and Epigenetic Reprogramming
Hochedlinger, K., & Jaenisch, R. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019448 · Cited by 111
Self-citationiPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter?
Scesa, G., Adami, R., & Bottai, D. (2021) · Cells · doi:10.3390/cells10061470 · Cited by 110
Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling
Koch, P., Kokaia, Z., Lindvall, O., & Brüstle, O. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70202-9 · Cited by 110
Human-induced pluripotent stem cells: potential for neurodegenerative diseases
Ross, C. A., & Akimov, S. S. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu204 · Cited by 110
Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53
Takenaka, C., Nishishita, N., Takada, N., Jakt, L. M., & Kawamata, S. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.11.003 · Cited by 110
Current Stem Cell Delivery Methods for Myocardial Repair
Sheng, C. C., Zhou, L., & Hao, J. (2012) · BioMed Research International · doi:10.1155/2013/547902 · Cited by 110
Metadata
- Authors
- Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- Hochedlinger, Konrad
- Venue
- Science
- Published
- 2008-11-07
- Volume
- 322
- Issue
- 5903
- Pages
- 945-949
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3987909
- OpenAlex
- W2050689355
- Cited by
- 1,683
- References
- 29
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 33 · 2023: 22 · 2022: 32 · 2021: 55 · 2020: 50 · 2019: 38 · 2018: 63 · 2017: 63 · 2016: 104 · 2015: 105 · 2014: 139 · 2013: 161 · 2012: 185
- FWCI
- 82.28
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1dp2od003266-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- induced pluripotent stem cells, Oct4, SOX2, KLF4, c-Myc, somatic cell reprogramming, DNA demethylation, teratoma, chimeric mice, fibroblasts, hepatocytes, insertional mutagenesis, patient-derived stem cells, embryonic stem cells
- MeSH terms
- Kruppel-Like Factor 4, Adenoviridae, Animals, Cell Differentiation, Cell Line, Chimera, Cloning, Molecular, Female, Fibroblasts, Genetic Vectors, Liver, Male, Teratoma, Genes, myc, Proto-Oncogene Proteins c-myc, Mice, SCID, Virus Integration, Transgenes, Hepatocytes, Pluripotent Stem Cells, Octamer Transcription Factor-3, Mice, Kruppel-Like Transcription Factors, SOXB1 Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.